Christopher Chipman
2021
In 2021, Christopher Chipman earned a total compensation of $415K as Chief Financial Officer at Virpax Pharmaceuticals, a 50% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $79,000 |
| Salary | $236,000 |
| Total | $415,000 |
Chipman received $236K in salary, accounting for 57% of the total pay in 2021.
Chipman also received $100K in bonus and $79K in option awards.
Rankings
In 2021, Christopher Chipman's compensation ranked 11,103rd out of 12,415 executives tracked by ExecPay. In other words, Chipman earned more than 10.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,103 out of 12,415 | 11th |
Division Manufacturing | 4,900 out of 5,508 | 11th |
Major group Chemicals And Allied Products | 2,186 out of 2,378 | 8th |
Industry group Drugs | 1,945 out of 2,099 | 7th |
Industry Pharmaceutical Preparations | 1,441 out of 1,549 | 7th |
Source: SEC filing on June 15, 2022.
Chipman's colleagues
We found two more compensation records of executives who worked with Christopher Chipman at Virpax Pharmaceuticals in 2021.